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The effect of various inhibitors of peptidoglycan synthesis on the 
ccraposition and patterns of metabolism of membrane phospholipid 
was studied in vtole cells and isolated membrane preparations. 
Bacitracin, vancomycin, and ristocetin, all of which block steps 
of cell wall synthesis involving the bactoprenol lipid carrier 
cycle, caused a marked elevation of the cardiolipin concentration 
with a corresponding decrease in phosphatidylglycerol- Pulse 
labeling studies revealed that phospholipid turnover was un­
affected, however, an as yet unidentified lipid (unknown A) was 
seen to accunulate. Bactoprenol intermediates were extracted from 
washed membranes, and on comparison it was found that the unknown 
A corresponded to the second of three major bands. Further 
characterisation of this unknown lipid by mild acid hydrolysis (in 
order to remove the end group from bactoprenol) yielded a product 
that was soluble in chloroform and chromatographed on SG 81 papers 
apparently as a phospholipid. Subsequent déacylation of this acid 
hydrolysis product revealed a glycerol phosphate ester, vAiose 
chromatographic properties were similar to the unknown described 
by Card (Card, G.L., J. Bacteriol. 114; 1125-1137, 1973.) Cardio­
lipin accumulation in vancomycin treated cells was shown to occur 
after a delayed response. Time dependent studies of the bacto­
prenol intermediates isolated from membranes treated with vanco­
mycin showed that as the unknown A decreased with respect to time, 
there was an apparent increase in bactoprenol-PP. This also 
corresponded with the increase in cardiolipin content. These 
results were interpreted as evidence for the coupling of phospho­
lipid metabolism with cell wall synthesis.
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Reality has no obligation to be interesting; only our 
hypotheses about it...
Jorge Luis Borges ” Death and the Compass "
Vlll
INTRODUCTION
The concept of the lipid bilayer as the principal mode of packing 
for lipids in biological membranes is new 50 years old, and in recent 
years this has been develĉ sed into the generally accepted Fluid Mosaic 
Model (110). There is now carpelling evidence that membranes are vect- 
torial structures; that is, there is an asyirmetric distribution of not 
only their protein constituents but also their phospholipid components 
(4, 8, '9, 82, 100, 101). The physiological relevance of phospholipid 
asymmetry is unknown. Asymmetric lipid canpositiais could possibly reg­
ulate differential membrane fluidity, or act as bilayer couples; here, 
they would differentially respond to perturbation (8). One clearly 
established fact is that there is no universal preference with regards to 
the bilayer distribution of a single phospholipid species (8, 82, 100).
Any model dealing with membrane bc x̂Dgraphy must allow for the mem­
brane's remarkable ability to maintain it's integrity. By changing it's 
phosjdTolipid composition, an organism has the means to withstand the 
pleiotrophic changes within it's environment. A ready interpretation in 
certain cases could be the maintenance of a suitable anionic surface 
charge. This can be readily achieved by an alteration of the distribu­
tion of the acidic and basic phospholipids within the membrane. The 
question of how an organian can adapt so readily remsdns unresolved. 
Phospholipids have an extremely high rate of lateral diffusion (62), 
vhereas trans-bilayer interchange (flip-flop), vhich is thermodynamically 
unfavorable, proceeds very slowly (8, 89). Rothman and Kennedy (99) vthen 
studying Bacillus megaterium, determined that the principal phospholipid, 
phosphatidylethanolamine (PE), is synthesised in an inteimal pool with 
subsequent rapid translocation to the extra-cytoplasmic side of the manr
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brane. They suggest that this rapid translocation on the order of 
three minutes - is due to catalysis by a specific membrane protein.
Membranes are ocmposed primarily of phospholipid and protein. Phos­
pholipids are an#iipathic molecules that account for 20-40% of the dry 
weight of bacterial membranes; the remainder representing the protein 
content. The hydrophylic and hydrophobic ends arise due to the unique 
structure of phospholipids. All phospholipids contain a glycerol back­
bone, to vhich fatty acids are usually esterified in the 1 and 2 posi­
tions. The polar head group is joined by a phosphodiester linkage to 
the 3 position of this diglyceride molecule. The distribution of the 
polar head groups determines the ccKçosition of the membrane. In reality, 
each individual phospholipid spaecies can change within itself. This is 
achieved by changing it's fatty acids. Changes resulting from this type 
of molecular rearrangement tend to ciffect membrane fluidity (25). The 
study of the biosynthesis of the individual phospholipid species, as 
determined ky the polar head group, has come under considerable attention 
in procaryotic organians during the past two decades, and it is this 
aspect that is the primary concern of this present study.
Phospholipid metabolian as determined for Escherichia coli.
The vast majority of this reseach has dealt with the Gram negative 
bacterium Escherichia coli. The phospholipid composition of E.coli 
wild-type cells is PE, phosphatidylglycerol (PG), and cardiolipin (CL), 
in the approximate ratios 70:20:10 respjectively. Kennedy and his cx>- 
workers (89) have been able to elucidate the biosynthetic p>athway from 
either glycerol or dihydroxyacetme to each of the individual phospho­
lipid species. The scheme paresented in Fig. 1 has been verified by
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three different experimental approaches. These are:
1. Classical deioistration of enzymes in crude extracts capable 
of catalysing these reactions;
2. Radioactive labeling to demonstrate the existance and turnover 
of such intermediates;
3. The isolation and lipid ccniposition of mutants defective in 
particular enzymes in Fig. 1.
Beginning with the acylaticxi of sn-glycerol-3-P, all of the reac­
tions occur on the cytoplasmic membrane (6/ 127). Phosphatidic acid (PA) 
formed frcm this initial acylation is next converted to a liponucleotide, 
CDP-diglyceride, by it's reacticxi with CTP. CDP-diglyceride is located 
at the biosynthetic branchpoint. Frcm here, phosphatidyl transferase 
reactions donate the phosphatidyl moiety to either the hydroxyl group 
of L-serine or to the hydroxyl group at the 1 position of sn-glycerol-3-P 
to form phosphatidylserine (PS) and phosphatidylglycerolphosphate (PGP) 
respectively. PS is rapidly decarboxylated to form PE: PGP is dephos-
phorylated to PG. PG however, is further metabolised by a condensation 
reaction to form CL. This latter reaction requires no metabolic energy. 
It has long since been recognised that PG is a rapidly metabolising 
molecule with ^>praxiinately 1/3 turning over in a single generation in 
E.coli (103).
All of the pressed enzymes in Fig. 1 have been at least partially 
purified and characterised to some extent. The lone exception is cardio­
lipin synthetase vhich we have found to be resistant to extraction by the 
use of detergents (unpublished chservation). The oatiroi pathway pro­
ceeds with the synthesis of PA. Membrane bound acyltransferases ester-
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Fig.l. The pathway of phospholipid metabolian as determined 
for Escherichia coli (89).
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ify positions 1 and 2 of sn-glycerol~3-P. Kito*s group (55, 56) has 
found that these reactions are activated by PG. The acyltransf erases 
appear to be the key regulatory enzymes in response to temperature 
fluctuations (25). Studies with a glycerol auxotroph under glycerol 
starvation, have revealed that the synthesis of the phosgholipids and 
fatty acids are co-ordinately controlled. During glycerol depletion, 
free fatty acid accumulates in the cytoplasm of the mutant (76). CDP- 
diglyceride synthetase is the enzyme that converts PA into the lipo- 
nucleotide. This enzyme, unlike others in the pathway, appears to have 
a specific requirement for an unsaturated fatty acid esterified to 
position 2 (89). Recently, Ganong and Raetz (37) have isolated a con­
ditionally lethal CDP-diglyceride synthetcise mutant in which there is a 
sharp elevation in PA content, with a corresponding decrease in PE and 
PG. The authors claim that the results "constitute definitive physio­
logical proof that CDP-diglyceride is an obligatory precursor for over 
90% of PE and PG in E.coli."
From CDP-diglyceride we find two different enzymes, phosphatidyl- 
serine synthetase (PSS) and g^sphatidylglycerolphosphate synthetase 
(PGPS), that ostensibly catalyse similar reactions; the transfer of the 
phosgjiatidyl grouç> from CDP-diglyceride to an alcohol.
In eucaryotic systems, the synthesis of PE involves a head group 
exchange reaction of L-serine and PE, followed by irreversible decarbox­
ylation (12, 27). However, in procaryotes, no such mechanism is known 
to occur. Also, PSS derived frcm bacteria could well be the one excep­
tion to the general observation that all the enzymes involved in the 
latter stages of ftosf^lipid biosynthesis are membrane bound. In vitro
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ribosaroal aussociation has been documented on nimerous occasions (30, 58,
92). Dowhan's groL^ (67) suggests that riboscmal associaticxi does occur 
in vitro, however they found that PSS is easily dissociated frcm this 
ccmplex by lipid substrates and they argue that this would indicate that 
the enzyme wuld not be closely associated with ribosones during actual 
catalysis within close proximetry of the membrane. When studying the 
kinetic parameters of the enzyme, Ishinaga (54) also noted the effect 
of various phospholipids. He found that CL and PE activated the enzyme, 
in contrast to PG*s inhibitory effect. Phospholipid compositions of 
E.ooli mutants for the PSS gene have shown a decrease in PE with a con­
comitant rise in CL when compared to wild-type (45, 78> 79). Raetz (91) 
has also shown that this rise in CL occurs in both the inner and outer 
manbranes of the PSS mutant. It is interesting to note that the PE con­
tent in any of the above mutants never falls below 25%.
Homogeneous PSS not only transfers the phosphatidyl group from CDP- 
diglyceride to L-serine, but also exchanges free CMP with the CMP moiety 
of CDP-diglyceride, and L-serine with PS (64, 93). These exchange reac­
tions suggest the possibility that there may well be a ping-pong type of 
reaction with the formation of an intermediary phosphatidyl complex (18,
93). values show that PSS has a very low affinity for L-serine (93). 
Utilising a mixed micellar system of Triton X-100 and CDP-diglyceride,
it was found that increasing the concentration of the detergent maximally 
stimulated the the PSS activity. This is consistent with "substrate 
dilution kinetics” in vAich an equilibrium ordered binding of the enzyme 
to a surface occurs prior to catalysis (18). Consequently, the stability 
of the phos#iatidy 1-enzyme ccnplex may be important in controlling the
7
ratio of the zwitterionic to acidic phospholipids if in fact PSS is only 
membrane boiind during catalysis.
The final step in converting CDP-diglyceride to PE occurs by a 
rapid decarboxylation of PS. Treatment of wild-type cells with hydrox- 
ylamine (an inhibitor of the decarboxylase enzyme) results in the accum­
ulation of large amounts of PS. This shows that in E.ooli decarboxyla­
tion represents the major biosynthetic route for the formation of PE 
in vivo.
The synthesis of PGP represents the first committed step towards 
the formation of PG and CL. PGPS catalyses the estérification of the 
1-hydroxyl group of sn-glycerol-3-P by the transfer of the gdiosphatidyl 
moiety from CDP-diglyceride (21). Consequently, the non-acylated 
glycerol of PGP is bound to the phosphatidyl groi:ç5 by a sn-glycerol-1- 
phosphodiester linkage. The occuranoe of this particular enantiomeric 
form of a glycerol phosphate bond is exceedingly rare (sn-glycerol-3-P 
being by far the most cannon in nature). PGPS is able to catalyse the 
reverse reaction. However, due to the highly irreversible nature of the 
dephosphorylation step that forms PG, the reaction is pulled in the for­
ward directicm (49). The homogeneous enzyme is specific for sn-glycerol- 
3-P but it's mode of action appears to differ from that of PSS. PGPS is 
unable to catalyse the exchange reactions between CMP and CDP-diglyceride, 
and sn-glycerol-3-P with PGP. Reversal of the reaction occurs by incu­
bating PGP with CMP (21, 49).
PGP has never been isolated from wild-type cells due to the rapid 
déphosphorylation ty phosphatidylglycerolphosphate phosphatase (22).
The phosphatase has a relatively high affinity for PGP and p>artially
8
purified fractions do not hydrolyse sn-glycerol-3-P at any significant 
rate (22).
Available evidence suggests that CL is undoubtedly fomed by the
stoichiometric condensation of two PG molecules to form CL and free
glycerol as shown fcy the following equation:
2 PG------ CL + glycerol.
The reaction requires no metabolic energy, and is supported by in vivo
evidence for the release of free glycerol from specifically labeled PG
molecules (3, 17, 41, 50, 70). This reaction was further substantiated
by in vitro CL synthesis using a particulate enzyme preparation from
Microooccus lysodeikticus (28). Characterisation of an E.coli mutant
deficient in the enzyme cardiolipin synthetase resulted in 15 fold less
CL and a 5 fold reduction in PG turnover (86). Definitive evidence for
the above reaction came from two independent studies. Utilising
Staphylococcus aureus. Short and White (106) showed that the fatty acids
and the phosphorus groiç>s from two PG molecules could be quantitatively
recovered in CL. Likewise, Hirschberg and Kennedy (50) dononstrated
0*5 3that when PG is doubly labeled with "̂ P̂ and H in the non-acylated 
glycerol of PG, that the ratio of recovered in CL was two times
greater than in PG. This would be ocxipatible with the above equation.
Both PG and CL are further metabolised in E.coli to a soluble 
extra-cytoplaanic product. Membrane-derived-oligosaccharide (MDO) con­
sists of sn-glycerol-l-P moieties from both PG and CL joined to carbon 
6 of glucose residues v^ch are preset in a glucose polymer (123). The 
formation of MDO and CL accounts for 75% of PG turnover in E.ooli (89). 
The presence of a diglyceride kinase, vAiich recycles sn-1,2-diglyceride
9
back to PA within the membrane, helps further to support the idea that 
MDO is derived frcm PG and CL (53, 95, 104). A double mutant, defective 
in both the kinase and MDO formation, caused a striking accumulation of 
diglyceride within the membrane (96). The presence of the kinase is 
interesting because it is well established (89) that acylation of sn- 
glycerol-3-P is the major de novo route of PA synthesis in vivo. The
availability of ATP on the inside of the membrane suggests a cytoplasmic
location for the kinase (96). If this were the case then it would 
necessitate the translocation of MDO across the membrane. An interest­
ing property of the enzyme is the strong effect exerted by CL? both
stimulatory and in the stabilisation of the enzyme itself (104). 
Regulation of phospholipid synthesis.
Clarification of our kncwledge as to the co-ordination of membrane 
lipid, membrane protein, and macrcmolecular synthesis in. growing cells 
would be greatly enhanced by the elucidation of the controls of phospho­
lipid metabolian. Early studies of phospholipid mutants demonstrated 
that genetic manipulation ves possible (47). With the advent of Raetz's 
selection procedure (87) for mutants defective in phospholipid metabolism 
we have seen a great accumulation of genetic information (88). As the 
greatest expense of energy within phospholipid biosynthesis is due to 
the synthesis of the fatty acids, one would therefore expect a certain 
degree of control to be exerted upon fatty acid availability. Indeed, 
there avgears to be a tight coupling of phosfbolipid and fatty acid 
syntheses in bacteria (76). Additional regulation could occur at areas 
in the metabolic pathway where ocmnon intermediates such as PA or CDP- 
diglyceride are formed. As yet, the control of CDP-diglyceride synthe-
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sis is ill defined. However, several mutants have been isolated for 
E.ooli that have defective genes for PSS and PGPS (36, 78, 80, 81, 88, 
94, 113). An important fact that appears to emerge frcm the above stud­
ies is that "the degree of cdteration of the phospholipid composition 
brought about by an increase in enzyme concentration is not in the order 
that would be expected if fluctuations in enzyme levels in vivo were an 
important regulatory raechanian in phospholipid metabolism (81)". It 
should be noted that drastic results do occur decreasing the concen­
tration of the phospholipid enzymes. Control vould then appear to be 
mediated either by modulating the enzymatic activity or by controlling 
the availability of necessary substrates. Studies with a trans-acting 
regulatory mutant of E.coli for the over production of PS revealed a 
regulatory locus distinct frcm the structural gene that it controlled 
(113). A similar method of control was also recognized with mutants 
defective in the gene coding for diglyceride kinase (90). Sparrow and 
Raetz (113) proposed that the control of PSS production is by "set- 
point" regulation. This is neither classical induction nor repression. 
Here the gene product is maintained at all times at a certain level by 
the action of a regulator.
Phospholipid metabolian in Gram positive organisms.
Vfe find that there are many striking similarities with regard to 
phospholipid metabolism in Gram positive organisms as those found in 
E.ooli. Early on it was recognised in both Bacilli and S.aureus that all 
the enzymes that are needed for the biosynthesis of PE, PG, and CL are 
paresent (73, 83, 106) and that the biosynthesis of each phospjiolipid 
species proceeds via the CDP-diglyceride intermediate (83). Character­
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isation of PSS (31) has demonstrated that CDP-diglyceride can act as a 
substrate for PS synthesis, and that the enzyme behaves in a similar 
fashion as that that was determined for E.coli's PGP. In vitro levels of 
PS decarboxylase were also reported. Comparable results have also been 
demonstrated for several other Gram positive organisms (19, 24, 63).
The glycerophosphatide sequence had been elegantly demonstrated by Short 
and White (106).
Phospholipid turnover in Gram positive bacteria also appears to 
bear sane similarity to that found in E.ooli. Although MDO has not been 
found in Gram positives, the turnover of PG shows sane resemblance in 
that the glycerophosphate groups of lipoteichoic acid appear to be de­
rived from this molecule (17, 32, 33, 61, 74).
Nevertheless, several pieces of evidence have surfaced (based prim­
arily from in vivo labeling studies) that suggest that an alternative 
pathway may exist in conjunction with the classic Kennedy scheme. Lang­
ley (63) has reported that PE was much more slowly labeled than the 
corresponding uptake PG. He found that at early times in the pulse,
PG sequestered 60 times more label than did PE (the letter's rate of 
labeling was carparable to that demonstrated by CL). îfe also found an 
elevated rate of PG turnover. Further pulse labeling studies with B.meg­
aterium (65, 66) showed there to be two distinct metabolic pools of PG. 
The use of trition shewed that the label was recovered in diglyceride 
on utilising a short pulse, and that rapid turnover of the non-acylated 
glycerol of PG occurred with the liberation of the label in free glycerol. 
To account for this, Lanbardi proposed the possibility of two intermedi­
ary complexes that would involve PG and two different acceptors to
12
provide:
1. Glycerophosphoryl groups for lipoteichoic acid with the release 
of diglyceride:
PG + X ----> glycerophosphoryl-X + diglceride
2. Phos#mtidyl grovqps for PE synthesis with the liberation of
free glycerol:
PG + Y ---- > phosphatidyl-Y + glycerol
Similar pulse chase studies with Bacillus stearothermophilus also 
revealed biphasic patterns of turnover for both PG and CL. These results 
vould suggest the existance of twD pools for each lipid; one metabolically 
active and one that was stable (17). Frcm the same study it was also 
shewn that turnover of CL and the phosphatidyl grou^ of PG caused the 
label to appear in lipoteichoic acid. To account for this Card further 
modified Lombardi's model in order to include CL synthesis:
PG + Y ---- > phosphatidyl-Y + glycerol
phosphatidyl-Y + PG > CL + Y
The glycerol so released could then be recovered in lipoteichoic acid 
with a recycling of the initial acceptor. It vas interest with regard 
to this proposed intermediary ccmplex that pronpted the present study. 
Phospholipid metabolism in relation to other cellular metabolic processes 
The regulation of macrcmolecular synthesis has ccme under a great 
deal of scrutiny during the past 20 years (.20, 26, 39, 43, 69, 73, 77).
In all these studies it was clearly understood that regulatory mechan­
isms must couple membrane metabolism with other macrcmolecular processes 
in order that balanced growth can be achieved. The molecular evidence 
in support of this conclusion is particularily scant. With the utilis­
ation of synchronous cultures, several authors reported a transient
13
increase in phospholipid synthesis immediately prior to cell division 
(.26, 43, 69). It has also been deteimined that phospholipid synthesis 
is coupled to DMA, RNA, and protein syntheses (20, 39, 40, 77). Studies 
with various systems have shown that the synthesis of membrane-associated 
protein is dependent upon phospholipid metabolism proceeding at a normal 
rate (20, 40, 77). The initial observation by Card that bacitracin (an 
inhibitor to cell wall biosynthesis) caused an increase in the CL content 
of exponentially growing cells, led us to believe that a possible direct 
correlation may exist between phospholipid metabolism and cell wall bio­
synthesis in B. stearothermophilus. Also, scattered references within 
the literature have often alluded to a correlation between changes in 
ftospholipid composition accompanying antibiotic resistance by a micro­
organism (2, 10, 29, 52, 122). This is especially interesting vdien the 
primary inhibitory mode of the antibiotic is directed at some target 
other than the cytoplaanic membrane. It appears that Gram positive 
organisms are more prone to this phencmencm than their Gram negative 
counterparts (.10, 29, 52).
Bacterial cell wall biosynthesis.
Bacterial cell wall biosynthesis and the study of antibiotic action 
are synonymous (35). From Card's initial observation with bacitracin, 
it appeared to us that attention should be focused primarily upon inhib­
itors of cell wall biosynthesis, with a special emphasis with regard to 
the inhibitors of the bactoprenol lipid carrier cycle. The pioneering 
work frcm Strcminger's laboratory (107) revealed the nature of this 
unique procaryotic carrier system, and this work is sunmarised in Fig. 2. 
Their work unequivocably demonstrated that the antimicrobial effect
14
UDP-MurlS^c-pentapeptide
P-lipid
Pi
Bacitracin
\
PP-lrpid
UMP
MurNAc(pentapeptide)-PP-lipid
UDP
GlcNAc-MurNAc (-pentapeptide) -PP-lipid
Glycine + ATP 
ADP + Pi
GlcNAc-MurNAc(- hexapeptide)-PP-lipid 
Vancomycin, Ristocetin
GlcNAc-MurNAc (rthexapeptide) -Acceptor Acceptor
Fig. 2. Reaction cycle of peptidoglycan synthesis in Micrococcus
lysodeikticus.(107)
IS
of bacitracin, a peptide antibiotic, to be due to the prevention of a 
crucial déphosphorylation step that is integral to cell wall synthesis. 
This occurred due to the formation of a oonplex between bacitracin, a 
divalent cation, and bactoprenol-PP (107, 116, 117, 118, 119).
The first step in the cycle involves a phospho-N-Acetyl-Muramyl- 
pentapeptide translocase (46). This is the first of several membrane 
bound enzymes. The reaction involves the transfer of N-Acetyl-Muramyl- 
pentapeptide fran a soluble nucleotide diphosphate precursor to the 
mono-phosçhorylated lipid carrier molecule to form the bactoprenol-PP- 
N-Acetyl-Murarayl-pentapeptide intermediate (121). Fran here, a second 
sugar residue is added, also utilising a nucleotide diphosphate deriv­
ative, and the nascent cell wall ocnçonent is coipleted by the addition 
of the cross-linking amino acids (35). It was determined that several 
of these enzymes involved in this initial series of events had carplex 
lipid requirenents (115, 121). The final translocation step of the 
ocmpleted disaccharide-pentapeptide moiety to an acceptor on the existing 
cell wall was determined by utilising the inhibitory action of the two 
aglycone antibiotics vanconycin and ristocetin (71, 75, 84, 85, 98).
Due to their interaction with acyl-p^tides that terminate with the 
sequence D-Ala-D-Ala, Wiich are the final two amino acids in the cross- 
linking peptide (84), these antibiotics prevented the polymerisation of 
the cell wall resulting in the accumulation of the bactoprenol-PP- 
disaccharide-pentapeptide intermediate (119). Fran here, the bacitracin 
sensitive step regenerates the initial bactoprenol-P acceptor due to the 
action of the enzyme bactoprenolpyrophosphate phosphatase and the cycle 
is complete (42).
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When assaying particulate enzyme preparations obtained fron S.aureus 
(48) / it was found that ATP had a marked stimulatory effect on peptido- 
glycan synthesis. It was subsequently determined that 90% of the bacto- 
prenol in S, aureus existed in the alcohol form (47). This and other 
data (38, 47, 48, 102, 129) have made the pressed, that a possible reg­
ulatory mechanism may be occuring by the combined action of two enzymes, 
a phosphokinase and a phos^iatase, that mediate bactoprenol-P avail­
ability appear most favorable. An unusual property of the phosphatase 
is that it has an optimal pH of 5. This is in contrast to the other 
enzymes in the cycle that operate around neutrality. Consequently, it 
is conceivable that pH gradierits across the monbrane are thereby a means 
for the cell to regulate peptidoglycan synthesis.
Further inhibitory action ascribed to bacitracin, vancomycin, and 
ristocetin.
In addition to these primary sites of action for the three anti­
biotics mentioned, numerous reports have appeared as to possible second­
ary effects that may also be attributable to than. For example, baci­
tracin has been shown to effect phospholipid metabolism in several 
microorganians by decreasing the ability to incorporate (^^C)-glycerol 
into the lipid fraction of Halobacterium cutirubrum (5) ; the excretion 
of cellular lipids from a number of Gram positive organisms into the 
medium (51) ; or in the case of S.aureus, to cause an increase in CL con­
tent with a proportional decrease in PG (59). Consistent with bacitra­
cin's inhibitory mode in procaryotes, the peptide has been a powerful 
tool in the study of glycolipid metabolism in eucaryotes. Studies 
utilising yeast membranes showed that bacitracin inhibited the transfer
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of N-Acetyl-gl\jc30samine from UDP-N^AcetylH31ucosamine to the isoprenoid 
carrier dolichyl-P; utilising porcine aorta microscmes, bacitracin 
afpeared to bind to the dolichyl-P itself (114) ; rat liver microscmes ̂ 
showed bacitracin inhibition to be directed at the formation of dolichyl-P 
frcm endogenous precursor (.60). In fact, bacitracin may well inhibit 
clI I  processes that involve polyisoprenoid intermediates as postulated 
by Stone and Stroninger (118).
Early reports of the inhibitory effects of vancomycin and ristocetin 
often alluded to possible secondary interacticn with the cytoplasmic 
membrane (44, 57, 98, 105, 132). Experiments designed to locate the 
site of action of the two antibiotics revealed that adsorption to the 
manbrane occured coincidently with binding to the cell wall (111). An 
iodinated vancomycin preparation showed that the affinity for the man­
brane was greater in vbole cell cultures than for isolated protoplasts 
(85). Labeling studies with ^^P and (^^C)-glycerol in Gram positive 
bacteria (57, 132) revealed that there was a marked decrease in the 
uptake into the lipid fraction on incubation with vancomycin. Vanco­
mycin also appears to have a selective effect on the synthesis of poly- 
glycero^ and polyribitolphosphate (13, 14). Using large concentrations 
of vancomycin (but not with ristocetin) caused a 60% decrease in the 
synthesis of teichoic acid. Ccaiseguently, the use of inhibitors to cell 
wall synthesis in persuing gainful information with regard to the study 
of phospholipid metabolism appears to already have some precedence 
within the literature.
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The proposed objectives of this study.
The objective of this study was to investigate the perturbation 
of phospholipid raetabolian caused by bacitracin, and determine v^ether 
in fact that cell wall synthesis and phospholipid metabolism are 
intimately linked. The specific aims were;
1. Identification of the lipid that accumulates on bacitracin 
treatment;
2. Quantification of the changes in lipid composition induced by 
the antibiotic;
3. An analysis of the changes in phospholipid synthesis and sub­
sequent turnover that are induced by bacitracin;
4. The determination of the effect of other inhibitors to cell 
wall synthesis on the phospholipid composition and metabolisn;
5. The isolation of bacitracin resistant mutants and an analysis 
of their phospholipid composition and metabolism.
MATERIALS AND METHODS
Grcwth conditions.
Bacillus stearothennophilus NCA 2184 was grown in a ccirplex medium 
(TYE) consisting of 2% Trypticase (BEL Microbiology Systems) and 1% 
yeast extract (Difco Laboratories). The cells were grown at 59 C in a 
shaking water bath. The larger culture volumes required for the isolation 
of washed membranes necessitated the use of a gyratory incubator shaker 
at the indicated temperature. Growth was monitored by the measurement 
of optical density at 600 nra in a Colenan Junior II spectrophotcmeter. 
Mutant isolation.
B. stearotherroophilus 2184 was mutagenised by N-methy 1-N ' -nitro-N- 
nitrosoguanidine by a slight modification of the procedure as outlined 
by Miller (72). At an optical density of 0.3, nitrosoguanidine (5(^/ml) 
was added to 50 ml of an exponentially growing culture and incubation 
was continued for a further 30 min at 59 C. The cells were then harvest­
ed on ice and washed With 20 ml of TÏE medium. The pellet from this 
washing step was diluted 1:10 and resuspended in 50 ml of prewarmed medium 
and further incubated until an optical density of 0.4 was reached. Por­
tions of the culture (0.1 ml) were pipetted onto bacitracin selection 
plates consisting of Trypticaise Soy Agar (BBL Microbiology Systems) with 
varying concentrations of bacitracin. Two individual colonies were picked 
fran the plates containing 10ŷ4g/ml of bacitracin. Growth in liquid cul­
ture was in a medium that consisted of the ccnplex medium previously des­
cribed to vhich was added bacitracin {10jû q/ml) and 0.5% glucose. The 
mutants were lyophilised and stored at -15 C.
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Lipid analysis.
The distribution of into the various lipid fractions was obtained 
by growing the cells in the TYE medium containing 2^Ci of per ml.
Relative specific activities (in counts per min per nmol of phosphate) 
for each phospholipid were determined.
Cells were either continuously labeled (for approximately five cell 
doublings), or pulse labeled for a specific period of time vhen the cul­
ture had reached an optical density of 0.24. Growth was terminated by 
pouring the cells over ice and removing the label by centrifugation at 
10,000 rpn.
Extraction of phospholipids.
Labeled cells were extracted by a modified Bligh and Dyer procedure 
(11). Cells from 10 ml samples were collected by centrifugation, resus­
pended in 0.8 ml of 0.3% NaCl and transferred to a screw-capped test 
tube. Three ml of chloroform/ethanol (1:2) were added to this screw^ 
capped tube and the single phase system was centrifuged using a clinical 
bench top centrifuge in order to pellet the particulate matter. The 
supematent was removed, further adjusted by the addition of 1 ml of 
chloroform and 1 ml of 0.3% NaCl that resulted in a two phase system 
with a chloroform/methanol/water ratio of 2:2:1.8. The chloroform phase 
was removed with a capillary pipette. A single drop of 5N HCl was then 
and the upper aqueous phase was reextracted twice with 1 ml of 
chloroform. The chloroform extracts were then pooled.
Card (15) had previously noted that lysozyme treatment of cells 
increcised the CL content of the lipid extract. Consequently, the de-
flipidated residue was resuspended in 0.8 ml of 50 itM Tris HCl and 5 mM
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MgCl2 containing 200yi>ig/inl lysozyme and incubated at 25 C for 30 min.
The reaction was stopped by the addition of 3 ml of chlorofornvtethanol 
(2:1) and the tubes were vigorously shaken at 60 C for 10 min. Further 
shaking for 30 min at roan temperature succeeded this heating step. A 
second Bligh and Dyer extraction as described above was then performed.
The choloform phases fron both extractions were pooled and taken to 
dryness.
The lipids were quantified either by chromatography in two dimensicxis 
on Whatman SG 81 papers or by déacylation by methanolysis and separation 
of the phosphate esters. The following solvent systems were used for 
chromatography on SG 81 papers: chlorofoiii\/methanol/2,6-dimethyl-4-hep-
tanone/acetic acid/water in the ratio 35:10:50:25:4 in the first direction 
and chlorofomv/methanol/2,6-dimethyl-4-heptanone/pyridine/0.5 M NH^Cl 
pH 9.8 in the ratio 60:30:45:70:12 in the second direction. Mild alka­
line hydrolysis was performed as described by White (128). The lipid 
extract was suspended in 0.5 ml of chloroform and an equal volume of 
0.2 M KOH in methanol was added. After incubatdon for two hours at 4 C, 
the solution was neutralised by repeated passage over Bio-rex 70 beads 
that had been prewashed with 2N HCl. At approximately pH 7, one ml of 
chloroform and one ml of 0.3% N^l were added and the solution was then 
subsequently vortexed for two minuts. The aqueous phase was removed 
and the lower organic phase was reextracted twice more with 0.5 ml of 
water. The aqueous extracts were pooled and taken to dryness. Separation 
of the ftesphate esters was by two dimensional chronatography on acid 
washed Whatman #1 papers. These were developed in the first dimension 
ty butanol/acetic acid/vater in the ratdo of 5:3:1, and in the second
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Phenol/0.1 N NH^OH (100:38 w/v).
Autoradiography using Kodak XAR-5 film or the procedure of Vaskovsky
and Kbtetsky (124) revealed the specific loci of each lipid or lipid
derivative. The spots were then either cut out and counted in a Beckman
3 32LS-750G programed for dual label H- P counting using Aquasol 2 (New 
England Nuclear Corp) as scintillation fluor, or in the case of certain 
SG 81 separations, the phos#iolipids were eluted fron the papers and 
then subjected to déacylation and rechromatographed as the phosphate 
esters.
Preparation of washed manbranes.
Membranes were prepared by the procedure as detailed by Sone et al. 
(112). The cells were grown in 200 ml of TYE medium to an optical den­
sity of 0.24, at vhich time they were harvested on ice and centrifuged 
for 30 min at 2500 rpn. The cells were then twice washed with 20 ml of 
0.15 M NaCl-50 mM Tris HCl (pH 7.8) -10 mM MgCl2. The washed cells were 
then treated with lysozyme (150yug/ml in the above buffer) for 20 min, 
after vhich time they were centrifuged at 10,000 rpm for 10 min. The 
pellet was then resuspended in 20 ml of 50 mM Tris HCl (pH 7.8), to vhich 
vas added 0.25 ml of DNase I (Sigma) (2 roq/ml in 50 mM Tris HCl (pH 7.8) 
-10 mM MgCl2) • This was then incubated for 10 min at 25 C. The bright 
red membrane pellet was obtained by centrifugation at 10,000 rpm for 30 
min. This was then washed once with 20 ml of 0.2 M NaCl-50 mM Tris HCl 
(pdl 7.8)-10 mM MgCl2/ subsequently thrice washed with 50 mM Tris HCl 
(pH 7.8)-10 mM MgCl2* Protein concentration was detennined by the method 
of Lowery et al. (68), using bovine serum albumin as the standard. An 
average amount of membrane protein obtained frcm a 200 ml culture was in
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the order of 2 mg.
Extraction procedure for isolating bactoprenol intermediates.
The method used was that described by Ward (125) for snail scale 
extractions fron prepared membranes. All glassware was silanised and 
all solutions were kept at 4 C due to the unstable nature of bactoprenol. 
Twd milligrams of labeled washed membranes were suspended in 1 ml 
of distilled water, to which was added an equal volume of butanol/6 M 
pyridinium acetate pH 4.2 (2:1 v/v). The system was separated into tvro 
phases and the upper butanol layer was removed by capillary pipette.
The aqueous phase was reextracted two more times with 0.5 ml of water- 
saturated butanol. The butanol extracts were combined and taken to 
dryness.
Further purification of this extracted lipid fraction was achieved 
subjecting the lipid extract to mild alkaline methanolysis as pre­
viously described. The material that remained soluble in the organic 
phase was chromatographed on Whatman LPH-K plates using 2,6-dimethyl-4- 
heptanone/acetic acid/water in the ratio 8:5:1 as the solvent. Auto­
radiography revealed the presence of the bactoprenol intermediates. 
Cardiolipin synthetase assay.
Cardiolipin synthetase was assayed by the following protocol: the
32incubation mixture contained 40^1 of P labeled manbrane, 100y^l of 
freshly prepared manbrane, ISOyMl of 0.2 M acetate buffer (pH 5.6) con­
taining 10 mM HTEA, and OOy^l aliquots of the aqueous antibiotic sol­
utions to give a final total volime of 0.4 ml. This was then incubated 
for 5 min at 60 C. The reaction was terminated by the addition of 1.5 
ml of chloroforn0nethanol/l N HCl (1:2:0.03). The controls were incu-
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bated at 0 C and 60 C without the presence of the specific antibiotics.
The phospholipids were isolated frcm this assay mixture hy adding 1 ml 
of 0.3% NaCl and 1 ml of chloroform. A two phase syston resulted and 
the chlorofoim layer was removed. The aqueous phase was reextracted 
two more times with 1 ml of chloroform. The chloroform extracts were 
pooled, taken to dryness, and chromatographed on SG 81 papers. 
Phospholipase D assay.
Authentic phosphatidic acid was obtained frcm either PG or PE by 
the method of Yang (130). PG and PE were eluted from SG 81 papers and 
the samples were taken to dryness. They were then resuspended in water 
by the means of ultrasonification and in this micellar form they were 
used as substrates for the reaction. The assay mixture was as follows: 
SOyUl of the resuspended lipid, 200y*l of 0.2 M acetate buffer (pH 5.6), 
lOOyiAl of the 0.4 M CaCl2/ and lO^wl phospholipase D (10 mg/ml) (Sigma).
The volume was adjusted to 0.4 ml with the buffer, to Wiich 0.5 ml of 
diethyl ether was overlaid. The mixture was incubated overnight on a 
wrist action shaker. The ether was then evaporated and 0.5 ml of chloro­
form and 1 ml of methanol were added to give a single phase syston. The 
solution was adjusted to a chloroforrn/methanol/water ratio of 2:2:1.8 
and the resulting chloroform phase was ramoved. The aqueous phase was 
reextracted two more times with 1 ml of chloroform. All the chloroform 
extracts were pooled, taken to dryness and chrcmatographed on SG 81 papers. 
Phosphorus assays.
Total inorganic phosphorus was determined by the ashing procedure 
described by Ames (1). The phos^iorus content from SG 81 papers was ob­
tained by dissolving the paper in 1 ml of 70% perchloric acid. This
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was then digested for four hours at 160 C. After cooling, 5 ml of deion­
ised water were added, followed by 0.5 ml of 2.5% ammonium mol^bdate 
and 0.5 ml of Fiske-Subba Row reagent in that order. The tubes were 
heated for 7h minutes at 95 C, centrifuged to remove the insoluble 
silica acid and read at 820 nm in a Coleman Junior II spectrophotcmeter. 
Phosphorus was determined by oonpariscn vâth known standards.
RESULTS
The effect of various inhibitors of cell wall metabolism on phospholipid 
conposition.
The major phospholipids of B. stearothennophilus are PG, PE, and CL 
which constitute about 45, 35, and 20% respectively, of the total lipid 
fraction of exponentially growing cells at 60 C (16). As shown in 
Table I, exposing exponentially cells to lO^g/ml of bacitracin, vanco­
mycin, and ristocetin all caused an elevation of CL frcm 20% to approx­
imately 45%, with a corresponding decrease in the amout of PG present.
In contrast, the phospholipid composition of cells incubated in the 
presence of penicillin and D-cycloserine were similar to control cultures 
where no antibiotic vas present. The effect of antibiotic concentration 
on the amount of CL synthesis is shown in Fig, 3. Increasing the con­
centration of bacitracin up to 250^  g/ml (at this point the cells were 
beginning to lyse) resulted in a linear increase of CL. A comparable 
effect was observed with low conentrations of both vancomycin and risto­
cetin (higher concentrations tended to cause the cells to revert back 
towards wild-type ̂ tosftolipid composition). Penicillin and D-cycloserine 
did not alter the phospholipid compositions at any concentration of the 
antibiotics.
A similar e)̂ )eriment to that described in Fig. 3 was performed with 
a mutant resistant to low concentrations of bacitracin and the results 
are depicted in Fig. 4. At low concentrations of bacitracin there 
appeared to be no effect on the amount of CL synthesis: at high con­
centrations the level was similar to that found using wild-type cells.
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Table I. Phospholipid ocmposition of B.stearothentpphiliis
in the presence of bacterial cell wall inhibitors.^
PE% PG% CL%
control^ 38 39 23
bacitracin 34 20 46
vancomycin 31 25 43
ristocetin 34 24 42
penicillin^ 35 39 25
cycloserine 34 38 28
^ The antibiotics were added to an exponentially growing culture at 
59 C at a final concentration of 10y(̂ g/ml for 20 minutes.
^ The control was identicail in all respects except that no antibiotics 
were present.
^ In this experirnent, the final concentration of penicillin was 5^g/ml 
due to cell lysis.
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Fig. 3. The effect of antibiotic concentration on the amount of
cardiolipin synthesis in wild-type cells.
A culture of B. stearothennophilus was grown at 59 C and 
was continuously labeled with until an critical density 
of 0.24. 10 ml sangles were then pipetted into flasks
containing the aqueous soluticHis of the antibiotics and 
the cells were further incubated for 20 min. The reaction 
was stopped by pouring the cells over ice and they were 
then centrifuged at 10,000 rpn for 10 min in order to 
remove the label. The phospholipids were extracted frcm 
the pellet by a modified Bligh and Dyer procedure (11).
The total lipid fraction was chrcmatographed in two 
dimensions on Whatman SG 81 papers utilising the following 
solvent systans : chloroform/raethanol/2,6-dimethyl-4-
heptanone/acetic acid/water in the ratio 35:10:50:25:4 in 
the first dimension, and chloroform/methanol/2,6-dimethyl- 
-4-heptanone/pyridine/0.5 M NH4CI pH 9.8 in the ratio 
60:30:45:70:12 in the second. Autoradiography revealed 
the presence of the lipids, v^ch were then cut out frcm 
the papers and counted in a Becknen LS-7500.
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Fig. 4. The effect of antibiotic concentration on the amount of
cardiolipin synthesis for a mutant resistant to low levels 
of bacitracin.
B. stearothennophilus was mutagenised by nitrosoguanidine 
(50^g/ml) and a single colony was isolated from bacitracin 
selection plates (10yug/ml). The mutant was then grown in 
liquid culture in TYE medium to vAiich was added bacitracin 
(10yug/ml) and 0.5% glucose under identical conditions as 
described in Fig. 3.
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Turnover patterns of cells labeled with P and exposed to bacitracin.
As shown in Fig. 5, the turnover patterns of bacitracin treated 
cells and control were similar. In both cases, PG was rapidly metabol­
ised, whereas PE and CL were relatively stable vAether the cells were 
chased in the presence of bacitracin or not.
The effect of bacitracin, vancomycin, and ristocetin on cardiolipin 
synthetase activity.
The effect on cardiolipin synthetase activity in washed membrane 
suspensions vdien assayed in the presence of the antibiotics is shown in 
Table II. As can be seen, there is little difference with the suspensions 
including the antibiotics to the 60 C control.
Characterisation of the unknown X.
Throughout the course of this study we noted the presence of an as 
yet unidentified lipid in the total lipid fraction (Fig. 6B). In wild- 
type cells this lipid accounted for less than 1% of the totcil lipid 
present. In exponentially growing cells subjected to 50yi4g/ml of baci­
tracin for 5 minutes, this particular conponent increased to 5% of the 
total lipid in the extract. This lipid was recovered frcm SG 81 papers 
by a conventional Bligh and Dyer extraction, and after mild alkaline 
methanolysis yielded a single phosphate ester vdiich we initially thought 
could be glycerol phosphate (Fig. 6C).
In order to ascertain whether the deacylated form of X originated 
frcm phosphatidic acid (as suggested by the above results), we chrcma­
tographed authentic PA with the unknown X on SG 81 papers. As can be 
be seen in Fig. 7, the acylated forms of X and PA appear to be two dis­
tinct molecules. Further confirmation of this fact was obtained by
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Fig. 5* The effect of bacitracin on the phospholipid turnover of
B.stearothennophilus.
32A culture continuously labeled with P until an opticail 
density of 0.24 was reached. The label was removed by cen­
trifugation and the cells were resuspended in TYE medium 
containing bacitracin (0.8yû g/ml). The culture was then 
further incubated for 20 minutes.
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Table II. The effect of bacterial cell wall inhibitors on the
in vitro assay of cardiolipin synthetase.^
PE% PG% CL%
bcontrol 0 C 32 46 23
control 60 29 10 61
bacitracin 25 12 63
vanconycin 26 13 61
ristocetin 29 10 61
^ The reaction was performed for 5 min with the incubation buffer con­
taining the antibiotics to a final concentration of 10yAg/hl.
^ Identical assay on ice in the absence of antibiotics.
^ Identical assay at 60 C in the absence of antibiotics.
36
Fig. 6. Twd dimensional chronatographic characterisation of the
unknown X; chronatogr^hy on SG 81 papers and chronatography 
of the E^sphate ester derived fron X.
The total lipid fraction was extracted as described in Fig. 3. 
Fig.SA. two dimensional chronatography on SG 81 papers of 
the toted, lipid fraction.
Fig.SB. Two dimensional chronatography on SG 81 papers of 
the total lipid fraction fron cells incubated in the presence 
of bacitracin (J50ytAg/ml for 20 min) revealing the position of 
of the unknown X. The unknown X was subsequently eluted 
fron the SG 81 papers and was then subjected to déacylation 
by mild alkaline methanolysis.
Fig.6C. Two dimensional chromatography of the phos#iate 
ester derived frcm X using Whatman # 1 papers developed 
with butanol/acetic acid/water in the ratio 5:3:1 in the 
first direction and phenol/0.1 N NH^OH (100:38 w/v) in the 
second direction.
Fig.6D. Two dimensional chronatography on Whatman # 1 
papers of the deacylated total lipid fraction.
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Fig. 7, T w  dimensional chronatography on SG 81 papers cotparing
the unkncwn X with authentic phosphatidic acid.
Autoradiographs of two dimensional separations using SG 81 
papers:
Fig.7A. X isolated fron Fig.6B and rechronatographed. 
Fig.7B. PA obtained by the action of phospholipase D using 
PG as substrate.
Fig.7C. X and PA (obtained by enzymatic action on PE) 
chronatographed together revealing two distinct molecules. 
Fig. 7D. Totcü. lipid fraction serving as control.
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œ-chronatographirig the glycerol phosphate esters of each lipid, and 
likewise, autoradiography revealed the presence of two spots (data not 
shown).
The effect of the addition of L-serine on the phospholipid composition 
of bacitracin treated cells.
If the phosphatidyl group of the suggested phosphatidyl intermediate 
can be used for PE synthesis, then the addition of L-serine might effect 
the phospholipid composition. This possibility was tested by increasing 
the serine concentration in the TYE medium at a fixed concentration of 
bacitracin. The results are shown in Fig. 8. Fran these data, we conclude 
that serine does not appear to have a significant effect on the phospho­
lipid metabolian of cells that have been simultaneously inhibited with 
bacitracin. Nonetheless, the PE content responded with a slight, but 
distinct, perturbation vhen the serine concentration was increased.
The effect due to varying the length of time that cells were in the 
presence of a fixed concentration of bacitracin.
The results presented thus far relied entirely upon the extraction 
procedure outlined in Materials and Methods. However, aiploying two 
relatively minor modifications designed to enhance the possibility of 
isolating a bactoprenol intermediate; namely, the use of silanised glass­
ware and performing the phospholipid extraction at 4 C, for all the steps 
other than the lysozyme treatment and the 60 C heating step, revealed 
the presence of several other unknown lipid species (Fig.9). Exposing 
the cells to 50^g/ml of bacitracin for 5 minutes caused the accumulation 
of a previously unseen lipid designated A. Performing the same experi­
ment but substituting vancomycin in place of bacitracin, also caused the
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Fig. 8. The effect of L-serine on the phospholipid coiposition of
cells treated simultaneously with a fixed concentration of 
bacitracin.
The same experiment was performed as described in Fig. 3 
except that bacitracin (50yug/knl) and L-serine were added 
together.
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Fig. 9, The time dependent effect of bacitracin on the phospholipid
ocnposition as revealed by W o  dimensional chromatography 
on SG 81 papers.
The same experiment was performed as described in Fig. 3 
except that the phospholipid extraction procedure was slightly 
modified by using silanised glassware and performing the 
extraction at 4 C, in order to aoccmadate the isolation 
of bactoprenol intermediates. The autoradiographs shew 
samples taken at 0 min, 5 min, 10 min, and 20 min, and 
reveal the presence of three lipids that were not previously 
isolated. These are designated as the unknowns A, B, and C.
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accmtulation of this particular lipid (data not shown). Further inspec­
tion of Fig. 9 showed that the unknown lipids B and C (tentatively ident­
ified as lyso-CL (Fig.lOD) and lyso-PE (Fig.KX:) respectively), decreased 
with respect to time after an initial transient increase.
Characterisation of the unknown lipid A.
The accumulated lipid (unknown A) was eluted from SG 81 papers by a 
conventional Bligh and Dyer procedure. After a brief period of acid 
hydrolysis (2 N H21 for 5 min at 100 C) and yet another Bligh and Dyer 
purification, the lipid that was remaining in the organic phase was re- 
chronatographed for a second time on SG 81 papers. A molecule with very 
similar migratory characteristics as demonstrated by the unknown X (Fig.TB) 
resulted. This acid hydrolysis product was recovered from this second 
SG 81 separation, subjected to déacylation and rechrcroatographed yet 
again, this time as the glycerol phosphate ester as shown in Fig.lOB.
This phosphate ester c^peared to correspond to a previously unidentified 
ester described by Card (15).
Further characterisation consisted of comparing the unknown lipid 
with bactoprenol intermediates isolated from prepared washed membranes.
As shown in Fig. 11, thin layer chromatography revealed the presence of 
three major bands for all membrane preparations. Intact unknown A 
(isolated prior to acid hydrolysis) appeared to correspond to the second 
of these major bands. Previous evidence (117) and the exacting nature 
of the extraction procedure, would clearly correlate all three bands 
with bactoprenol. If that is so, and that the unknown A does in fact 
correspond to the second band, then we conclude that our accumulated 
phospholipid due to bacitracin inhibition is ccmposed in part with the
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Pig. 10. Characterisation of the unknowns A, B, and C by two dimen­
sional chromatography of their phosphate esters.
The three lipids were eluted from the SG 81 chromatographs 
shown in Fig. 9. Unknown A was then subjected to mild acid 
hydrolysis (2 N HGl for 5 min at 100 C) in order to remove 
the end group from bactoprenol. The acid hydrolysis product, 
and the unknowns B and C were then subjected to mild alka­
line methanolysis and chromatographed as described in Fig. 6. 
The phosphate ester of C was tentatively identified glycerol 
phosphate ethanolamine (Fig. IOC) ; the phosphate ester of B 
was tentatively identified as glycerylphosphoglycerylphospho- 
glycerol, the jdK)sphate ester resulting from CL (Fig.lOD) ;
A still remains unknown (Fig.lOB); Fig.lOA is the toted, 
lipid control.
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Fig. 11. Thin layer chromatography of bactoprenol intermediates 
isolated from prepared membranes.
P washed manbranes were prepared from 200 ml cultures by 
the method detailed by Sone CH2). Bactoprenol was extracted 
into butanol using butanol/6 M pyridinium acetate pH 4.2 
(2:1 v/v). This total lipid extract was further purified by 
mild alkaline methanolysis and the material that remained 
soluble in the organic ftese was then separated on Whatman 
LPH-K plates using 2,6-dimethyl-4-heptanone/acetic acid/water 
in the ratio 8:5:1 as the solvent. Autoradiography revealed 
the presence of the bactoprenol.
V»
o_
T0
3
(Q
I control
^01^. b a c itra c in  5 0 p g /m .
vancomycin 10 p g /m l
01^ vancomycin 50 p g /m l
I
bacitracin  50 ug/m l 
( V 2 the exposure t im e )
VO
50
C^g-isoprenoid oanplex.
The time dependent effect of vanocnycin on the lipid ocrnposition of 
washed membranes.
EîÇ)onentially growing cells were inhibited with SCyMg/ml of vanoo- 
mycin and samples were taken at various times thereafter. The harvested 
cells were then extracted for either phospholipid or bactoprenol. Fig.l2A 
shows that the elevation of CL occurs scmetime after 10 minutes from the 
start of the inhibitory period. This is in contrast to bacitracin v^ere 
this rise occured prior to 5 minutes (Fig. 7). Thin layer chromatogr^hy 
of the bactoprenol intermediates isolated from the cells harvested at 
various times during the inhibitory period is shown in Fig.l2B. Upon 
close inspection, it appeared that the first band increased with respect 
to time with a corresponding decrease in the second band (our postulated 
phosfholipid intermediate). This coordinated effect also appeared to 
correspond with the elevation of CL.
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Fig. 12. The effect of time on vanoonycin treated cells as revealed
by two dimensional chrcroatography on SG 81 papers of the 
total lipid fraction y and by thin layer chromatography of 
bactoprenol intermediates isolated from washed membranes.
Fig.l2A demonstrates the delayed elevation of the CL content 
in an analogous experiment as to the one described in Fig. 9. 
Fig.l2B shows the separation of the bactoprenol intermed­
iates isolated from washed membrane samples as described 
in Fig. 11 that were taken at various times during the 
inhibitory period.
All antibiotic concentrations were SOyAg/ml.
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DISCUSSION
The data presented in Table I and Fig. 3 show that on exposing 
B.stearothennophilus to twenty minutes of antimicrobial action, that one 
can readily see that bacitracin and low concentrations of vancomycin and 
ristocetin all cause a sharp rise in the CL content; apparently at the 
expense of PG. The lack of this response with penicillin and D-cyclo*- 
serine would suggest the possible involvement of the bactoprenol carrier 
system. A similar effect was recently documented with S.aureus (59).
The results that are sunmarised in Table II would tend to suggest that 
this increase did not appear to be due to a direct effect of the anti­
biotics on cardiolipin synthetase activity. Also, it would appear from 
Fig. 5 that bacitracin is not exerting an effect on phospholipid turnover, 
albeit that in this experiment lew concentrations of bacitracin were 
used.
Fig. 6 clearly demonstrates that an unidentified lipid (X) was seen 
to accumulate on bacitracin treatment and initially we thought the phos­
phate ester derived from X was possibly glycerol phosphate. If this were 
the case then this would have been consistent with Card's proposal (17) 
that increased CL synthesis should result in a greater number of phos­
phatidyl complexes. However, two dimensional chromatography of the 
unknown X with authentic PA clearly showed the existance of two different 
molecules. Also, we failed to demonstrate a significant increase in PE 
content with a simultaneous addition of bacitracin and L-serine to an 
eaqxonentially growing culture. These two pieces of data tend to support 
Dowhan's contention (31) that PG is not metabolised via a phosphatidyl 
complex. However, in light of Kito's (131) recent exchange data of PG 
with PE in a serine auxotroph of E.coli, and some particularily puzzling
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studies on PE synthesis in Gram positive anaerobic organisms (19, 108,
109) would serve to ranind us that further clarification of this point 
is needed.
The hope of possibly isolating a bactoprenol intemediate led us to 
slightly modify the #K)spholipid extraction procedure. The detection of 
three additional lipids using this modification (Fig. 9) was particularily 
encouraging. Fran a cursory visual inspection the unknown designated A 
appeared to bear sane apparent differences frcm the other well-character­
ised phospholipids present. (This particular unknown also accumulated 
in the corresponding experiment using vanoanycin-data not shown). Subt 
sequent characterisation of A showed that mild acid hydrolysis (to release 
any end group from bactoprenol) yielded a product that was soluble in 
chloroform and that chronatographed as a single spot. This appeared to 
correspond to the position of the unknown X using SG 81 papers as shown 
in Fig.TB. The deacylated end group (Fig. 10) turned out to be yet another 
glcerol phosphate ester when compared to deacylated X. With this in mind, 
the observation of the chromatographic properties of the end group and the 
unknown X would appear to suggest that though they have been shewn to be 
different molecules they may be chsnically related.
Finally, attention was focused on the isolation from washed msnbrane 
preparations of the bactoprenol intermediates thanselves. It was hoped 
that if bactoprenol was involved with phospholipid metabolism then changes 
in the phospholipid catçosition caused by the presence of the antibiotics 
would be reflected at the bactoprenol level. As Fig. 11 shows, the extract 
from each nWbrane preparation appeared to consist of three major bands • 
Previous evidence (117) documents a single major band identified as bacto-
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prenol-PP, however, a second analler, unidentified band was also detected. 
Chronatogr^hing isolated intact unknown A (i.e. prior to acid hydrolysis) 
on thin layer plates shewed that this canpound migrated with the second 
of these major bands. Vte believe that this is particularily strong evi­
dence for the involvanent of bactoprenol in phospholipid netabolism. 
Further suj^rt of this contention is found in the results depicted in 
Fig. 12. In this experiment we relied upon the fact that vancaitycin did 
not cause an inroediate increase in the CL content, and this was shown at 
the bactoprenol level by a diminishment of the phospholipid intermediate 
accanpanying the elevation of CL. Close inspection of the bacitracin 
lane in Fig. 12 shows that most of the label appeared to be present in the 
first of these major bands (evidence to date would suggest that this ccm- 
pound is bactoprenol-PP (117) ), Not only was the diminishment of our 
phospholipid intermediate reflected in the rise in CL concentration but 
it also appeared to be in conjunction with an increase of bactoprenol-PP.
Fran the evidence presented thus far, it can be seen that two funda­
mental questions remain with regards to the accunulated phosftolipid 
product. They are: what is the molecular nature of this particular
jtosftolipid intermediate? and what is the role that this purported 
intermediate plays with regard to phospholipid metabolism?
As yet the molecular identity of the intermediate A is unknown. The 
evidence presented in Fig. 11 would strongly implicate the presence of 
bactoprenol in this intermediate, but doubt still remains as to the 
identity of the end group. Various factors would suggest that the unknown
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X and the acid hydrolysis product are derived frcm the same molecule.
This conclusion is based upon such things as the effect of modifying the 
extraction procedure vhich resulted in the disappearance of X with the 
appearance of the unkncwn A; the sporadic isolation of X, that could be 
accounted for by it's attachment to bactoprenol; and the extreqrely similar 
chromatographic behaviour exhibited by both molecules. (In fact with 
regard to this latter point, the only difference is in the deacylated 
state using the solvent system butanol/acetic acid/water). The chrcma- 
tographic properties exhibited by X and the acid hydrolysis product in 
the two systems described herein, with their apparent analogous suscept­
ibility to mild alkaline hydrolysis would suggest the possibility of a 
phosg^lipid end group joined to bactoprenol. However, neither of the 
two molecules were found to correspond to PA (Figs. 6, 7, and 10), yet 
this is by far the most plausible explanation for a bactoprenol-phospho- 
lipid complex of this nature. This would in fact correspond to a phos­
phatidyl intermediate. In fact neither the acylated nor deacylated 
products appeared to correspond to any readily identifiable lipid in 
either system.
Speculation as to the possible identity of the end group invariably 
leads one to consider PG turnover. It has long been believed that the 
elucidation of PG turnover would appear to solve many of the ocmplexities 
we now face concerning phospholipid metabolism. Recently, Card (17) 
presented evidence that the turnover of the phosphatidyl group of PG in 
B. stearothermoFhilus resulted in the label being incorporated in lipo- - 
teichoic acid. Consequently, the possibility could in fact exist that 
the accumulated unknown gAospholipid intermediate may be involved in
58
lipoteichoic acid synthesis. With regard to this possibility, an inter­
esting property of both X and the acid hydrolysis product in the deacylated 
form is that the bulk of the label applied to the papers in Figs.6C and 
lOB remained at the origin. This could possibily indicate the presence 
of a chanically unfavorable group or the presence of a polymer of some 
nature that remains at the origin due to seme possible physicad constraints.
Turning our attention now to the possible role that our proposed 
bactoprenol phospholipid intermediate could play in phospholipid metabolisn 
we find that several questions deserve further consideration.
Initially, our thoughts on the possible inhibitory effects of baci­
tracin were that an analogous situation to cell wall biosynthesis was 
occuring within phospholipid metabolian, namely, that bactoprenol-P would 
be acting as the possible acc^>tor for the phosphatidyl complex that Card 
proposed. However, the data from Fig. 3 clearly show that upon increasing 
the bacitracin concentration there is a correspcxiding incresise in CL con­
tent. It has been determined that increasing the amount of bacitracin 
would increase the level of bactoprenol-PP and not bactoprenol-P, so con­
sequently, the possibility now arises in that bactoprenol-PP may itself 
stimulate CL synthesis by possibly acting as the initial acceptor in order 
to form the intermediary ccnç>lex. One problem with this hypothesis is 
that neither vancomycin nor ristocetin has ever been associated with the 
accumulation of bactoprenol-PP as a consequence of their inhibitory action 
(35). However, the results in Fig. 12 would in fact appear to support this 
line of reasoning. Here it appears that the phospholipid intermediate 
decreases with respect to time with an elevation of CL that also corres­
ponded to an increase in bactoprenol-PP.
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A possible explanation to account for this anonalous behaviour with 
the vanccmycin treatment could be as follows. Inihibition of the 
translocase step, vMch results in the accumulation of the intennediate 
bactoprenol-PP-disaccharide-pentapeptide in cell wall biosynthesis, osten­
sibly removes bactoprenol from the system. Consequently, the cell in 
trying to provide bactoprenol-P (apparently the crucial acceptor in the 
bactoprenol lipid carrier cycle) breaks down the phospholipid intermediate 
and as a result of this causes an elevation of CL and the formation of 
bactoprenol-PP. The latter would then be subsequently dephosphorylated 
to bactoprenol-P. This explanation would not account for bacitracin's 
almost identical effect: bacitracin treated cells have an inoperable
phosphatase enzyme and would be unable to produce the desired bactoprenol-P.
A further question that arises is at Wiat particular stage does 
bactoprenol enter into ^tospholipid metabolism? The answer to this partr 
icular question is also unknown. Without knowing the identity of the end 
group nor the form of the initial acceptor make speculation on bactoprenol 
entry in phospholipid metabolism engaging but as yet unfortunately fruit­
less. Possible approaches as to solving this particular impasse and the 
one regarding the identity of the end group could be the use of dual 
label studies with the detemination of the ^^P/^H ratio in the acid 
hydrolysis product; in vitro assays of cardiolipin synthetase in \diich 
the incubation buffer is siiçjplonented with either the unknown A or bacto­
prenol-PP and deteimining the relative ratios of the particular products; 
chanical tests to determine the exact nature of the unknown A could in­
clude the use of mass spectroscopy and nuclear magnetic resonance-
Nonetheless, the results presented here constitute particularily
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évidence for th6 ooupllng of cell wall synthesis and phospholipid 
metabolism. The fact that bactoprenol should appear in a phospholipid 
ccnplex should not appear too surprising. Evidence is now rapidly 
accumulating (23, 34, 125, 126) that would appear to suggest that the 
synthesis of teichoic acids also involves a bactoprenol intermediate. As 
teichoic acids are believed to be synthesised in part frcm phospholipid 
degradation, then the occurance of a ccrnnon reaction vehicle would appear 
quite plausible. A critical aspect of this particular scenario would be 
the particularily fine control that the cell could exert on macrcmolecular 
synthesis. This could be achieved by possibly regulating the flow of 
bactqprenol intermediates that may be serving as acceptors for each 
individual reaction sequence. Strcminger's groL^ (38, 47, 48, 102, 129) 
believes that cell wall synthesis is regulated by the dual action of a 
kinase and pho^hatase that maintain the appropiate levels of bactoprenol-P. 
An interesting property of this system is that the phosphatase enzyme 
has an equivalent pH optimum as the one that we have determined for cardio­
lipin synthetase. These two enzymes are in sharp contrast to the rest 
of the phospholipid and cell wall enzymes, vhose pH optima are all within 
the range of 7-8. Consequently, the possibility exists that both phospho­
lipid and cell wall biosynthesis may well be controlled by pH gradients 
across the cytoplasmic membrane.
SUMYIARY
The results obtained from this study can be sunmarised as follows:
1. Bacitracin and low concentrations of vanocn^cin and ristocetin (all 
of which have been determined to inhibit the bactoprenol lipid 
carrier cycle in cell wall synthesis) all cause a marked elevation 
of CL apparently at the expense of PG;
2. This elevation does not appear to be due to the antibiotics inter­
fering with phosEtolipid turnover nor by than exerting an effect on 
cardiolipin synthetase activity;
3. Depending i^n the extraction procedure, two different lipid inter­
mediates, A and X, were seen to accumulate on antibiotic treatment. 
They have been partially characterised and they appear to bear sane 
similarity with each other based on their chromatographic properties. 
It would appear that the unknown A is composed in part by the C55- 
isoprenoid lipid bactoprenol (based on comparative thin layer chrana- 
tograE^y) and possibly a phospholipid moiety, the identity of which 
is as yet unknown;
4. When bactoprenol intermediates were specifically isolated from washed 
manbranes, it was demonstrated that one of three major bands corres­
ponded to the unknown A. It was also shown that our accumulated 
phospholipid intermediate apparently diminished with respect to time, 
with a concomitant incirease in bactoprenol-PP vhen the cells were 
subjected to vancomycin inhibition. This also coordinated with 
the elevation of CL;
5. Vfe believe that the data presented here provides evidence for the 
coupling of manbrane and cell wall metabolians.
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